 오퍼게시판 |
|
|
제 목:
|
Tirzepatide |
|
등록분류: |
Offer to Sell |
|
내용: |
CAS NO: 2023788-19-2
Additional_detail: Tirzepatide is the world's first ?dual GIP/GLP-1 receptor agonist. It exerts its therapeutic effects by simultaneously targeting two key receptors:
(1) ?Glucose-dependent insulinotropic polypeptide (GIP) receptor?: Enhances insulin secretion and suppresses glucagon, improving glycemic control.
(2) ?Glucagon-like peptide-1 (GLP-1) receptor?: Delays gastric emptying, increases satiety, and promotes glucose-dependent insulin release.
This dual mechanism provides synergistic metabolic benefits, demonstrating superior efficacy compared to single-target agents.
|
연락처 |
| 담
당 자: |
Xie Wen Feng |
| 회사주소: |
16/F,Huicheng Comm,Complex,No839 XiaHe Rd, Xiamen,China |
| 전화번호: |
+86-592-5881089 |
| 팩스번호:
|
+86-592-5854960 |
| E - mail: |
xie@china-sinoway.com |
|
현재위치
: Home > Trade 
